Article
SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity.
Frontiers in immunology - 1 Jan 2022
Liu Haolin, Wei Pengcheng, Kappler John W, Marrack Philippa, Zhang Gongyi
Abstract excerpt
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has lasted more than 2 years with over 260 million infections and 5 million deaths worldwide as of November 2021. To combat the virus, monoclonal antibodies blocking the virus binding to human receptor, the angiotensin converting enzyme 2 (ACE2), have been approved to treat the infected patients. Inactivated whole virus or the full-length...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
